Nanotechnology Methods for Neurological Diseases and Brain Tumors (Enhanced Edition) Nanotechnology Methods for Neurological Diseases and Brain Tumors (Enhanced Edition)

Nanotechnology Methods for Neurological Diseases and Brain Tumors (Enhanced Edition‪)‬

Drug Delivery across the Blood–Brain Barrier

    • $154.99
    • $154.99

Publisher Description

Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood-Brain Barrier compiles the latest (and future potential) treatment strategies for brain tumors and neurological diseases, in particular Alzheimer’s, Parkinson’s and stroke, those that bypass the blood/brain barrier.

The current understanding of brain drug delivery and access is discussed in Chapter One, with the next section focusing on the implementation of the nose-to-brain intranasal route in brain-targeted drug delivery.

In addition, nanotechnology-based brain drug delivery is covered in Chapter Three. This avenue offers impressive improvement in the treatment of neurological diseases and brain tumors by using bio-engineered systems that interact with biological systems at a molecular level. In Chapter Four, emphasis is placed on the need for brain-targeted experimental models that mimic disease conditions. Final chapters discuss the very latest advances in targeted treatment strategies for neurological diseases and brain tumors. Comprehensive guide for up-to-date views on the latest advances in targeted treatment strategies for brain tumors and neurological diseases Designed with a multidisciplinary approach that links neurology, neuro-oncology and nanoscience to drug delivery to the brain with an emphasis on the blood-brain-barrier Written in a language that makes it easy to understand nanotechnology drug delivery techniques Presents a unique book that also covers advanced treatment approaches of neurological diseases and brain tumors

GENRE
Professional & Technical
RELEASED
2017
14 July
LANGUAGE
EN
English
LENGTH
378
Pages
PUBLISHER
Elsevier Science
SELLER
Elsevier Ltd.
SIZE
18.1
MB